CRYO-SAVE Group, the Netherlands-based stem cell company with a large Indian presence, plans to increase the number of stem cell donors
in the country by opening more representative offices. The company expects this would increase the number of clients and also extend its reach beyond the current five cities, group CEO Rob Koremans told ET.
Cryo-Save Group plans to invest e 2 million (about Rs 13 crore) in its Bangalore-based subsidiary for over three years.
Stem Cell Research Study Reveals Stroke Patients Helped by Own Stem Cells
A new stem cell research study/trial recently completed shows that implanting a person’s own Adult Stem Cells helps stroke patients overcome partial paralysis. Dr. Kameshwar Prasad of the All India Institute of Medical Sciences (AIIMS) will present his stem cell study […]
As Aaditya watches a cartoon show on television, his right hand wavering to caress soft toys (SpongeBob SquarePants and Noddy) tucked next to him in bed, the boy has no clue that researchers and doctors across the world are watching his recovery with bated breath.
That’s because this frail boy, who is set to turn eight next month, is the first ever to receive a stem cell transplant for a rare and destructive illness — called Childhood Alzheimer’s (medical term: Niemann-Pick Type C or NPC), which causes neurological degeneration and seizures — for which there is no conventional treatment. Stem
Image via Wikipedia
Patients suffering from blindness now need not wait for donors as doctors have found a way to treat many with the stem cells derived from the cornea of a dead body.
Doctors at the AIIMS and a private clinic in the national capital are using corneal surface stem cells from a cadaver’s (dead person) eye for curing corneal injuries in many.
“We have used the corneal surface stem cells of cadaver’s eye for patients with corneal injury and have been able to correct many vision,” Dr Radhika Tandon, Associate Professor, Department of Opthalmology, AIIMS said, adding “this has been